These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 27043012)

  • 41. Role of procalcitonin in managing adult patients with respiratory tract infections.
    Schuetz P; Amin DN; Greenwald JL
    Chest; 2012 Apr; 141(4):1063-1073. PubMed ID: 22474148
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia.
    Müller B; Harbarth S; Stolz D; Bingisser R; Mueller C; Leuppi J; Nusbaumer C; Tamm M; Christ-Crain M
    BMC Infect Dis; 2007 Mar; 7():10. PubMed ID: 17335562
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel electronic algorithm using host biomarker point-of-care tests for the management of febrile illnesses in Tanzanian children (e-POCT): A randomized, controlled non-inferiority trial.
    Keitel K; Kagoro F; Samaka J; Masimba J; Said Z; Temba H; Mlaganile T; Sangu W; Rambaud-Althaus C; Gervaix A; Genton B; D'Acremont V
    PLoS Med; 2017 Oct; 14(10):e1002411. PubMed ID: 29059253
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PROCalcitonin-based algorithm for antibiotic use in Acute Pancreatitis (PROCAP): study protocol for a randomised controlled trial.
    Siriwardena AK; Jegatheeswaran S; Mason JM; Baltatzis M; Chan A; Sheen AJ; O'Reilly D; Jamdar S; Deshpande R; de Liguori Carino N; Satyadas T; Qamruddin A; Hayden K; Parker MJ; Butler J; Rajai A; McIntyre B
    Trials; 2019 Jul; 20(1):463. PubMed ID: 31358032
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care.
    Briel M; Schuetz P; Mueller B; Young J; Schild U; Nusbaumer C; Périat P; Bucher HC; Christ-Crain M
    Arch Intern Med; 2008 Oct; 168(18):2000-7; discussion 2007-8. PubMed ID: 18852401
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Procalcitonin for guidance of antibiotic therapy.
    Schuetz P; Albrich W; Christ-Crain M; Chastre J; Mueller B
    Expert Rev Anti Infect Ther; 2010 May; 8(5):575-87. PubMed ID: 20455686
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.
    Christ-Crain M; Jaccard-Stolz D; Bingisser R; Gencay MM; Huber PR; Tamm M; Müller B
    Lancet; 2004 Feb; 363(9409):600-7. PubMed ID: 14987884
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Procalcitonin: should it be measured systemically?].
    Luong Ba K; Harbarth S; Carballo S
    Rev Med Suisse; 2013 Oct; 9(402):1881-2, 1884-5. PubMed ID: 24298711
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A PCT algorithm for discontinuation of antibiotic therapy is a cost-effective way to reduce antibiotic exposure in adult intensive care patients with sepsis.
    Kip MM; Kusters R; IJzerman MJ; Steuten LM
    J Med Econ; 2015; 18(11):944-53. PubMed ID: 26105574
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Observational multi-centre, prospective study to characterize novel pathogen-and host-related factors in hospitalized patients with lower respiratory tract infections and/or sepsis - the "TAILORED-Treatment" study.
    van Houten CB; Oved K; Eden E; Cohen A; Engelhard D; Boers S; Kraaij R; Karlsson R; Fernandez D; Gonzalez E; Li Y; Stubbs A; Moore ERB; Hays JP; Bont LJ
    BMC Infect Dis; 2018 Aug; 18(1):377. PubMed ID: 30086729
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Infection biomarkers in primary care patients with acute respiratory tract infections-comparison of Procalcitonin and C-reactive protein.
    Meili M; Kutz A; Briel M; Christ-Crain M; Bucher HC; Mueller B; Schuetz P
    BMC Pulm Med; 2016 Mar; 16():43. PubMed ID: 27009083
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of procalcitonin on the management of children aged 1 to 36 months presenting with fever without source: a randomized controlled trial.
    Manzano S; Bailey B; Girodias JB; Galetto-Lacour A; Cousineau J; Delvin E
    Am J Emerg Med; 2010 Jul; 28(6):647-53. PubMed ID: 20637377
    [TBL] [Abstract][Full Text] [Related]  

  • 53. PLUS-IS-LESS project: Procalcitonin and Lung UltraSonography-based antibiotherapy in patients with Lower rESpiratory tract infection in Swiss Emergency Departments: study protocol for a pragmatic stepped-wedge cluster-randomized trial.
    Bessat C; Bingisser R; Schwendinger M; Bulaty T; Fournier Y; Della Santa V; Pfeil M; Schwab D; Leuppi JD; Geigy N; Steuer S; Roos F; Christ M; Sirova A; Espejo T; Riedel H; Atzl A; Napieralski F; Marti J; Cisco G; Foley RA; Schindler M; Hartley MA; Fayet A; Garcia E; Locatelli I; Albrich WC; Hugli O; Boillat-Blanco N;
    Trials; 2024 Jan; 25(1):86. PubMed ID: 38273319
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and Safety of Procalcitonin-Guided Antibiotic Therapy in Lower Respiratory Tract Infections.
    Drozdov D; Dusemund F; Müller B; Albrich WC
    Antibiotics (Basel); 2013 Jan; 2(1):1-10. PubMed ID: 27029288
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Procalcitonin measurements for guiding antibiotic treatment in pediatric pneumonia.
    Esposito S; Tagliabue C; Picciolli I; Semino M; Sabatini C; Consolo S; Bosis S; Pinzani R; Principi N
    Respir Med; 2011 Dec; 105(12):1939-45. PubMed ID: 21959024
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Procalcitonin-guided Antibiotics in Respiratory Infections (PARI) project in general practice - a study protocol.
    Filipsen N; Bro H; Bjerrum L; Jensen JS; Aabenhus R
    BMC Prim Care; 2022 Mar; 23(1):43. PubMed ID: 35279069
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Procalcitonin utilization in the real world: An observational study of antibiotic prescribing practices.
    Choi JJ; Cornelius-Schecter A; Hayden JA; Jannat-Khah DP; O'Connell A; Baduashvili A; Lee J; McCarthy MW
    J Eval Clin Pract; 2020 Aug; 26(4):1220-1223. PubMed ID: 31667954
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Procalcitonin guidance for reduction of antibiotic use in low-risk outpatients with community-acquired pneumonia.
    Long W; Deng X; Zhang Y; Lu G; Xie J; Tang J
    Respirology; 2011 Jul; 16(5):819-24. PubMed ID: 21507143
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of procalcitonin-guided decision-making to shorten antibiotic therapy in suspected neonatal early-onset sepsis: prospective randomized intervention trial.
    Stocker M; Fontana M; El Helou S; Wegscheider K; Berger TM
    Neonatology; 2010; 97(2):165-74. PubMed ID: 19776651
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Drivers of antibiotic prescribing in children and adolescents with febrile lower respiratory tract infections.
    Gotta V; Baumann P; Ritz N; Fuchs A; Baer G; Bonhoeffer JM; Heininger U; Szinnai G; Bonhoeffer J;
    PLoS One; 2017; 12(9):e0185197. PubMed ID: 28957358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.